
Molecular Devices is one of the world's leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over 1,000 associates are guided by our diverse leadership team and female president that prioritize a culture of collaboration, engagement, diversity, and inclusion. Molecular Devices is proud to be part of Danaher. Danaher's science and technology leadership puts Molecular Devices' solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher's other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day. To learn more about how Molecular Devices helps fast-track scientific discovery, visit www.moleculardevices.com.
Unlock the market timeline & signal feed
23 signals in the last 90 days.
The order this company entered each market — oldest to newest
Senior Director, European Sales (m/f/d)
Field Service Engineer
Sign up to see the full signal feed
How Molecular Devices's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
Molecular DevicesYou | 6 | 1 | -87% | 9 | 37 |
Warehouse/Logistics Operator (f/m/d)
View postingPuch bei Hallein, Salzburg, Austria · 3d ago
3D Application Scientist (m/f/d)
View postingPuch bei Hallein, Salzburg, Austria · last wk.
Finance Analyst
View postingShanghai, Shanghai, China · last mo.
AI Solutions for Pharma and Large Biotech
Active🧬Have you registered for 2026 Scientific Forum?https://lnkd.in/gWCY62XSJoin us to explore how scientists across Europe are advancing reproducibility in complex biological research through automation, AI‑enabled execution, and intelligent workflow design.This free event will explore topics including:- Scaling reproducible human‑relevant biology using automation and AI‑enabled execution- Imaging and analysing complex biological models with confidence- Designing and operating robust automated work ...
EndedJoin us at SLAS Europe 2026
EndedMolecular Devices introduces ImageXpress HCS.ai, an advanced high-content imaging system for scientific research and drug development, featuring improved imaging quality and AI-powered analysis.
Molecular Devices introduces QPix FLEX, an innovative microbial clone screening system with integrated liquid handling, high-resolution imaging, and anaerobic compatibility.
Molecular Devices launches SpectraMax iD3s and iD5e microplate readers, offering advanced features for life science research including dual injectors, cell-based assays, and flexible wavelength selection.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Molecular Devices's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.